Ftse Mib
34.657,35
0,93%
DAX
18.772,85
0,50%
S&P 500
5.222,68
0,16%
NASDAQ
16.340,87
-0,03%
Bitcoin
61.342,10
0,89%

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NYSE Bio Rad Laboratories Inc (BIO.B) Bio Rad Laboratories Inc (BIO.B) Notizie

BIO.B

Bio Rad Laboratories (BIO.B)

HOME News News di Agenzia

News di Agenzia

Da:
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NYSE:BIO.B
DataOraFonteTitoloSimboloCompagnia
18/04/202415:00Business WireBio-Rad to Report First Quarter 2024 Financial Results on Tuesday, May 7, 2024NYSE:BIO.BBio Rad Laboratories Inc
10/04/202422:15Business WireBio-Rad’s Chief Operating Officer Andrew Last to RetireNYSE:BIO.BBio Rad Laboratories Inc
11/03/202414:59Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NYSE:BIO.BBio Rad Laboratories Inc
29/02/202423:24Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:BIO.BBio Rad Laboratories Inc
29/02/202400:24Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNYSE:BIO.BBio Rad Laboratories Inc
21/02/202422:31Edgar (US Regulatory)Form 8-K - Current reportNYSE:BIO.BBio Rad Laboratories Inc
16/02/202422:31Edgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]NYSE:BIO.BBio Rad Laboratories Inc
15/02/202422:15Business WireBio-Rad Reports Fourth-Quarter and Full-Year 2023 Financial ResultsNYSE:BIO.BBio Rad Laboratories Inc
27/10/202322:31Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NYSE:BIO.BBio Rad Laboratories Inc
27/09/202322:07Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNYSE:BIO.BBio Rad Laboratories Inc
15/06/202323:13Edgar (US Regulatory)Report of Proposed Sale of Securities (144)NYSE:BIO.BBio Rad Laboratories Inc
07/06/202317:32Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NYSE:BIO.BBio Rad Laboratories Inc
05/06/202314:46Edgar (US Regulatory)Current Report Filing (8-k)NYSE:BIO.BBio Rad Laboratories Inc
24/05/202322:51Edgar (US Regulatory)Specialized Disclosure Report (sd)NYSE:BIO.BBio Rad Laboratories Inc
05/05/202322:32Edgar (US Regulatory)Quarterly Report (10-q)NYSE:BIO.BBio Rad Laboratories Inc
29/03/202322:37Edgar (US Regulatory)Annual Report to Security Holders (ars)NYSE:BIO.BBio Rad Laboratories Inc
29/03/202322:32Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)NYSE:BIO.BBio Rad Laboratories Inc
09/02/202317:14Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NYSE:BIO.BBio Rad Laboratories Inc
08/02/202314:00PR Newswire (US)Element Biosciences and Bio-Rad Partner to Deliver Seamless RNA Sequencing Workflow Between Element's AVITI™ System and Bio-Rad's SEQuoia™ Express and SEQuoia™ Complete Stranded RNA Library Prep KitsNYSE:BIO.BBio Rad Laboratories Inc
06/05/202218:25Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NYSE:BIO.BBio Rad Laboratories Inc
11/04/202222:46Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NYSE:BIO.BBio Rad Laboratories Inc
25/02/202213:23Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(2) (424b2)NYSE:BIO.BBio Rad Laboratories Inc
24/02/202212:08Edgar (US Regulatory)Free Writing Prospectus - Filing Under Securities Act Rules 163/433 (fwp)NYSE:BIO.BBio Rad Laboratories Inc
23/02/202214:40Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)NYSE:BIO.BBio Rad Laboratories Inc
08/02/202116:19Edgar (US Regulatory)Statement of Ownership (sc 13g)NYSE:BIO.BBio Rad Laboratories Inc
21/12/202017:09Edgar (US Regulatory)Amended Statement of Changes in Beneficial Ownership (4/a)NYSE:BIO.BBio Rad Laboratories Inc
02/03/202013:55Edgar (US Regulatory)Annual Report (10-k)NYSE:BIO.BBio Rad Laboratories Inc
27/08/201923:17Edgar (US Regulatory)Amended Current Report Filing (8-k/a)NYSE:BIO.BBio Rad Laboratories Inc
04/03/201913:02Edgar (US Regulatory)Notification That Annual Report Will Be Submitted Late (nt 10-k)NYSE:BIO.BBio Rad Laboratories Inc
26/04/201822:47Edgar (US Regulatory)Amended Annual Report (10-k/a)NYSE:BIO.BBio Rad Laboratories Inc
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NYSE:BIO.B

La tua Cronologia

ASX
GSL
GreatCell Solar
Delayed Upgrade Clock
Per accedere al tempo reale push di Borsa è necessario registrarsi.

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' CLICCA QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network